Advertisement
Singapore markets closed
  • Straits Times Index

    3,300.04
    -3.15 (-0.10%)
     
  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     
  • Dow

    38,852.27
    +176.59 (+0.46%)
     
  • Nasdaq

    16,349.25
    +192.92 (+1.19%)
     
  • Bitcoin USD

    63,596.23
    -68.02 (-0.11%)
     
  • CMC Crypto 200

    1,319.84
    -45.28 (-3.32%)
     
  • FTSE 100

    8,316.11
    +102.62 (+1.25%)
     
  • Gold

    2,325.40
    -5.80 (-0.25%)
     
  • Crude Oil

    77.91
    -0.57 (-0.73%)
     
  • 10-Yr Bond

    4.4510
    -0.0380 (-0.85%)
     
  • Nikkei

    38,835.10
    +599.03 (+1.57%)
     
  • Hang Seng

    18,479.37
    -98.93 (-0.53%)
     
  • FTSE Bursa Malaysia

    1,605.68
    +8.29 (+0.52%)
     
  • Jakarta Composite Index

    7,123.61
    -12.28 (-0.17%)
     
  • PSE Index

    6,618.58
    -33.91 (-0.51%)
     

This Beaten-Down Growth Stock Has Significant Upside Potential. Time to Buy?

This Beaten-Down Growth Stock Has Significant Upside Potential. Time to Buy?

Shareholders of medical technology company InMode (NASDAQ: INMD) have not had a great 2022; the stock has fallen roughly 50% since the beginning of the year. Here are three reasons to consider InMode as a long-term growth stock for your portfolio. InMode designs and builds non-invasive medical equipment for cosmetic procedures like face and body contouring, hair removal, and women's wellness.